BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 31664100)

  • 1. Priming with a recombinant pantothenate auxotroph of Mycobacterium bovis BCG and boosting with MVA elicits HIV-1 Gag specific CD8+ T cells.
    Chapman R; Shephard E; Stutz H; Douglass N; Sambandamurthy V; Garcia I; Ryffel B; Jacobs W; Williamson AL
    PLoS One; 2012; 7(3):e32769. PubMed ID: 22479338
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of HIV-1 antigens in plants as potential subunit vaccines.
    Meyers A; Chakauya E; Shephard E; Tanzer FL; Maclean J; Lynch A; Williamson AL; Rybicki EP
    BMC Biotechnol; 2008 Jun; 8():53. PubMed ID: 18573204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro sensitization of T cells with DC-associated/delivered HIV constructs can induce a polyfunctional CTL response, memory T-cell response, and virus suppression.
    Kurle S; Thakar M; Shete A; Paranjape R
    Viral Immunol; 2012 Feb; 25(1):45-54. PubMed ID: 22233251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DCs for HIV vaccine?
    Nat Rev Microbiol; 2007 Mar; 5(3):172. PubMed ID: 17310536
    [No Abstract]   [Full Text] [Related]  

  • 5. The immunogenicity of p24 protein from HIV-1 virus is strongly supported and modulated by coupling with liposomes and mannan.
    Zachová K; Bartheldyová E; Hubatka F; Křupka M; Odehnalová N; Turánek Knötigová P; Vaškovicová N; Sloupenská K; Hromádka R; Paulovičová E; Effenberg R; Ledvina M; Raška M; Turánek J
    Carbohydr Polym; 2024 May; 332():121844. PubMed ID: 38431385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protection against tuberculosis achieved by dissolving microneedle patches loaded with live
    Lee MH; Seo H; Lee MS; Kim BJ; Kim HL; Lee DH; Oh J; Shin JY; Jin JY; Jeong DH; Kim BJ
    Front Immunol; 2023; 14():1178688. PubMed ID: 37398665
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Li Y; Zhang W; Zhao J; Lai W; Zhao Y; Li Y; Qu J
    Emerg Microbes Infect; 2022 Dec; 11(1):1973-1981. PubMed ID: 35916253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COVID-19 vaccine development based on recombinant viral and bacterial vector systems: combinatorial effect of adaptive and trained immunity.
    Lee MH; Kim BJ
    J Microbiol; 2022 Mar; 60(3):321-334. PubMed ID: 35157221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant
    Kim BJ; Jeong H; Seo H; Lee MH; Shin HM; Kim BJ
    Front Immunol; 2021; 12():712274. PubMed ID: 34512635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaccine strategies for the
    Sharan R; Kaushal D
    NPJ Vaccines; 2020; 5():95. PubMed ID: 33083030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mycobacterial codon optimization enhances antigen expression and virus-specific immune responses in recombinant Mycobacterium bovis bacille Calmette-Guérin expressing human immunodeficiency virus type 1 Gag.
    Kanekiyo M; Matsuo K; Hamatake M; Hamano T; Ohsu T; Matsumoto S; Yamada T; Yamazaki S; Hasegawa A; Yamamoto N; Honda M
    J Virol; 2005 Jul; 79(14):8716-23. PubMed ID: 15994765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advances and challenges in recombinant Mycobacterium bovis BCG-based HIV vaccine development: lessons learned.
    Kilpeläinen A; Maya-Hoyos M; Saubí N; Soto CY; Joseph Munne J
    Expert Rev Vaccines; 2018 Nov; 17(11):1005-1020. PubMed ID: 30300040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant Mycobacterium bovis BCG as an HIV vaccine vector.
    Chapman R; Chege G; Shephard E; Stutz H; Williamson AL
    Curr HIV Res; 2010 Jun; 8(4):282-98. PubMed ID: 20353397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential of recombinant Mycobacterium paragordonae expressing HIV-1 Gag as a prime vaccine for HIV-1 infection.
    Kim BJ; Kim BR; Kook YH; Kim BJ
    Sci Rep; 2019 Oct; 9(1):15515. PubMed ID: 31664100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of a Live Recombinant BCG Expressing Human Immunodeficiency Virus Type 1 (HIV-1) Gag Using a pMyong2 Vector System: Potential Use As a Novel HIV-1 Vaccine.
    Kim BJ; Kim BR; Kook YH; Kim BJ
    Front Immunol; 2018; 9():643. PubMed ID: 29636755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prime-boost vaccination using recombinant Mycobacterium bovis BCG and recombinant vaccinia virus DIs harboring HIV-1 CRF01_AE gag in mice: influence of immunization routes.
    Promkhatkaew D; Matsuo K; Pinyosukhee N; Thongdeejaroen W; Leang-Aramgul P; Sawanpanyalert P; Warachit P
    Southeast Asian J Trop Med Public Health; 2009 Mar; 40(2):273-81. PubMed ID: 19323012
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.